NCT07227584 2025-11-12ALL Backbone in AYAsDana-Farber Cancer InstitutePhase 2 Not yet recruiting67 enrolled
NCT06649422 2024-10-18Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter StudyShandong UniversityNot yet recruiting36 enrolled